Experienced in Bronchogenic Cyst

Shinichiro Mori

St. Luke's International Hospital
Tokyo, JP 
Experienced in Bronchogenic Cyst
St. Luke's International Hospital
Tokyo, JP 
OverviewLocationsClinical Research

Overview

Shinichiro Mori practices in Tokyo, Japan. Mori is rated as an Experienced expert by MediFind in the treatment of Bronchogenic Cyst. Their top areas of expertise are Colorectal Cancer, Pneumomediastinum, Stomach Cancer, Ileostomy, and Gastrectomy.

Their clinical research consists of co-authoring 205 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Bronchogenic Cyst.

Locations

St. Luke's International Hospital
Tokyo, Japan
Other Locations
Kagoshima, Japan
Chiba, Japan
St Luke's International Hospital
Chuo, Japan
Inage, 2638555, Japan
8908520, Japan
Saitama, Japan
Ariake, Japan
Hirakata, Japan
Moriguchi, 5708506, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

An Open-Label Single-Arm Phase 1 Study Evaluating Safety of Itacitinib in Combination With Corticosteroids for the Treatment of Steroid-Naive Acute Graft-Versus-Host Disease in Japanese Subjects
An Open-Label Single-Arm Phase 1 Study Evaluating Safety of Itacitinib in Combination With Corticosteroids for the Treatment of Steroid-Naive Acute Graft-Versus-Host Disease in Japanese Subjects
Enrollment Status: Completed
Publish Date: March 03, 2020
Intervention Type: Drug
Study Phase: Phase 1

205 Total Publications

Comparison of myeloablative Busulfan/Cyclophosphamide and Busulfan/Fludarabine for Allogeneic HSCT: A Systematic Review and Meta-analysis: Short title: Bu/Cy vs. Bu/Flu Conditioning Meta-analysis.
Comparison of myeloablative Busulfan/Cyclophosphamide and Busulfan/Fludarabine for Allogeneic HSCT: A Systematic Review and Meta-analysis: Short title: Bu/Cy vs. Bu/Flu Conditioning Meta-analysis.
Journal: Transplantation and cellular therapy
Published: October 13, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mori's expertise for a condition
ConditionClose
    View All 8 Advanced Conditions
    View All 47 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile